Cargando…
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Adiponectin is the most abundant peptide secreted by adipocytes, whose reduction plays a central role in obesity-related diseases, including insulin resistance/type 2 diabetes and cardiovascular disease. In addition to adipocytes, other cell types, such as skeletal and cardiac myocytes and endotheli...
Autores principales: | Achari, Arunkumar E., Jain, Sushil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486142/ https://www.ncbi.nlm.nih.gov/pubmed/28635626 http://dx.doi.org/10.3390/ijms18061321 |
Ejemplares similares
-
A Potential Interplay between HDLs and Adiponectin in Promoting Endothelial Dysfunction in Obesity
por: Zocchi, Monica, et al.
Publicado: (2022) -
Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer’s Disease
por: Kim, Jong Youl, et al.
Publicado: (2020) -
Adiponectin as a therapeutic target for diabetic foot ulcer
por: Abdalla, Mona Mohamed Ibrahim, et al.
Publicado: (2023) -
l-Cysteine and Vitamin D Co-Supplementation Alleviates Markers of Musculoskeletal Disorders in Vitamin D-Deficient High-Fat Diet-Fed Mice
por: Parsanathan, Rajesh, et al.
Publicado: (2020) -
Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
por: Fisman, Enrique Z, et al.
Publicado: (2014)